Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Jan 15, 2022; 14(1): 334-347
Published online Jan 15, 2022. doi: 10.4251/wjgo.v14.i1.334
Published online Jan 15, 2022. doi: 10.4251/wjgo.v14.i1.334
Exosomal content | Sample | Expression | Isolation of exosomes | Content detection | Function | Ref. |
HCC | ||||||
miRNAs | ||||||
miR-122 | Serum (n = 75) | Down | SBI | qRT-PCR | Reflect the liver damage and residual liver function levels | [47] |
Plasma (n = 150) | Down | SBI | qRT-PCR | Significantly lower in patients with HCC compared with cirrhotic patients and the control group | [22] | |
miRNA-1298 | Serum (n = 120) | Down | exoRNeasy Serum/Plasma MidiKit (Qiagen) | qRT-PCR | Down-regulated in patients of hepatocellular carcinoma compared with patients of hepatitis C virus and normal good health control | [39] |
miR-320a | Serum (n = 209) | Down | SBI | qRT-PCR | Associated with lymph node metastasis, vein invasion, TNM stage, and survival of HCC patients | [48] |
miR-320d | Serum (n = 150) | Down | Total Exosome Isolation Kit (Invitrogen) | qRT-PCR | Associated with clinicopathological parameters and prognosis of HCC patients | [49] |
miR-638 | Serum (n = 147) | Down | Total Exosome Isolation Kit (Invitrogen) | qRT-PCR | Influence liver carcinogenesis | [50] |
miR-718 | Serum (n = 59) | Down | Ultracentrifugation | qRT-PCR | Significantly different expression of HCC cases with recurrence after LT compared with those without recurrence | [51] |
miR-744 | Serum (n = 20) | Down | Ultracentrifugation | qRT–PCR | Facilitates the propagation and drug resistance of HCC cells | [52] |
miR-9-3p | Serum (n = ?) | Down | Ultracentrifugation | qRT-PCR | A potential therapeutic target for HCC | [53] |
lncRNAs | ||||||
lnc-EPC1-4 | Serum (n = 180) | Down | Ultracentrifugation | qRT-PCR | Function as a tumor suppressor gene | [35] |
SENP3-EIF4A1 | Serum (n = 6) | Down | SBI | qRT-PCR | Block HCC progression | [54] |
circRNAs | ||||||
circ-0051443 | Plasma (n = 120) | Down | SBI | qRT-PCR | Suppress HCC progression | [55] |
HB | ||||||
miRNAs | ||||||
miR-34s | Serum (n = 152) | Down | SBI | qRT-PCR | Significantly lower in patients with HB compared with the control group | [56] |
- Citation: Wei XC, Liu LJ, Zhu F. Exosomes as potential diagnosis and treatment for liver cancer. World J Gastrointest Oncol 2022; 14(1): 334-347
- URL: https://www.wjgnet.com/1948-5204/full/v14/i1/334.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i1.334